Vesdee Shop PelviLift

Clinical evidence report

Research Behind PelviLift

A clear, consumer-readable review of pelvic floor electrical stimulation research, FDA 510(k) context, and what the evidence can and cannot support.

Key finding 01

Clear Main Claim

The strongest evidence supports pelvic floor electrical stimulation for stress-related leakage, pad-test leakage reduction, and pelvic floor muscle activation.

Key finding 02

Honest Comparison

Electrical stimulation can outperform no treatment or sham use, but evidence does not consistently show that it is superior to well-guided pelvic floor muscle training.

Key finding 03

Careful Extension

Postpartum, midlife, and intimate-confidence language should be framed as support and education, not as a promise to treat sexual dysfunction or menopause-related conditions.

Regulatory context

Built on FDA 510(k)-cleared continence stimulation technology.

The referenced device platform for PelviLift is associated with FDA 510(k) K213116, a Class II nonimplanted electrical continence device under 21 CFR 876.5320, product code KPI. FDA 510(k) clearance means substantial equivalence to a legally marketed predicate device. It is not the same as FDA premarket approval.

510(k)
K213116
Device class
Class II
Regulation
21 CFR 876.5320
Product code
KPI

Official source: FDA 510(k) database entry for K213116

Mechanism

NMES helps make pelvic floor training feelable.

Kegels only work when the right muscles can be found and contracted. Pelvic floor neuromuscular electrical stimulation sends controlled pulses that can help activate weak or hard-to-engage pelvic floor muscles, supporting neuromuscular re-education over repeated sessions.

Activate

Gentle stimulation helps create a contraction when muscles feel weak or hard to find.

Repeat

Consistent sessions guide activation and recovery cycles instead of guesswork.

Re-educate

Repeated activation supports the nerve-muscle connection involved in control.

Evidence map by symptom

Organized by what women actually want to improve.

The evidence is strongest when it is grouped by the consumer problem, not by publication date. For PelviLift, the clearest order is leakage first, then muscle activation, urgency, postpartum weakness, and finally intimate-confidence education.

01 / Strongest evidence

Stress leaks, pad weight, and leakage frequency

This is the clearest evidence area for pelvic floor electrical stimulation. Studies and reviews support active stimulation over no active treatment or sham use for stress-related leakage and pad-test outcomes.

  • Naidu et al. 2026: 6 of 8 RCTs reported significant reductions in pad use, 10 of 15 reported lower pad weight, and 8 of 14 reported fewer leakage episodes after intravaginal electrical stimulation.
  • Sand 1995: active stimulation improved leakage volume by at least 50% in 62% of women, compared with 19% using sham stimulation.
  • Castro 2008: pelvic floor training, electrical stimulation, and vaginal cones were all effective and superior to no active treatment.
  • Cochrane Stewart 2017 and Han 2021 both support electrical stimulation as a studied conservative option for female SUI.
02 / Best Vesdee differentiation

Weak muscles that are hard to activate

PelviLift should not be positioned as “better than Kegels.” Its clearest differentiation is helping women who cannot reliably find or activate the pelvic floor muscles needed for Kegels to work.

  • PMID 34952812: women unable to voluntarily contract pelvic floor muscles improved voluntary contraction ability after intravaginal electrical stimulation.
  • Li 2020 studied postpartum women with extremely weak pelvic floor muscles and supports the “wake up before training” explanation.
  • Mechanism language should focus on guided activation, feelable contraction, and neuromuscular re-education.
03 / Supportive evidence

Urgency, night urination, and bladder-control signals

Urgency-related evidence is promising but should be written carefully. It can support education around bladder-control signals, not a cure claim.

  • Kurt 2024: external NMES plus lifestyle advice improved urgency urinary incontinence outcomes compared with sham plus lifestyle advice.
  • Chen 2024 and Yu 2024 summarize nonimplantable or intravaginal stimulation research across urinary symptoms.
  • Consumer wording should say “supports urinary control routines” or “helps calm urgency-related training pathways.”
04 / Life-stage education

Postpartum and midlife pelvic floor support

Postpartum evidence can support weak-muscle and re-activation education. Midlife and menopause should be treated as user contexts, not independent treatment claims.

  • Cai 2023 meta-analysis supports electrical stimulation therapy for postpartum pelvic floor dysfunction outcomes.
  • Li 2020 supports the concept of stimulation protocols for extremely weak postpartum pelvic floor muscles.
  • Midlife language should stay with bladder confidence and pelvic floor support, not vaginal atrophy or GSM treatment.
05 / Education only

Intimate confidence and sexual-function-related outcomes

Pelvic floor function is related to intimate confidence, but sexual function evidence for electrical stimulation is mixed. This belongs in education, not headline claims.

  • Aydın 2015 found limited between-group sexual function differences, with satisfaction as the main domain difference.
  • Aalaie 2021 found both biofeedback and electrical stimulation improved scores, with biofeedback showing greater benefit.
  • IPSU trial evidence supports restraint: no physical therapy form clearly outperformed another for overall sexual function.

Evidence boundaries

What we can say clearly, and what we should not overstate.

Supported

  • Pelvic floor electrical stimulation has been clinically studied for urinary leakage.
  • Active stimulation can perform better than no treatment or sham conditions.
  • Electrical stimulation may help women who struggle to activate weak pelvic floor muscles.
  • PelviLift can be described as supporting pelvic floor activation and bladder control routines.

Not overstated

  • Do not claim electrical stimulation is always better than well-guided Kegels or PFMT.
  • Do not claim guaranteed treatment, cure, or reversal of urinary incontinence.
  • Do not make sexual-function treatment claims based on mixed and limited evidence.
  • Do not claim broad quality-of-life improvement as a primary proven outcome.

Selected studies

Clinical references used to inform Vesdee education.

Customer question Evidence to cite What it supports Marketing boundary
“Can this help with leaks when I laugh, cough, or move?” Sand 1995; Castro 2008; Stewart 2017 Cochrane; Han 2021; Yu 2024 network meta-analysis Pelvic floor electrical stimulation is clinically studied for stress-related leakage and pad-test outcomes. Say “supports bladder control” and “clinical studies on stimulation show reductions.” Avoid “cure.”
“What if I can’t feel or find the right muscles?” PMID 34952812; Li 2020; Cai 2023 Stimulation can support activation and re-education in women with very weak or hard-to-contract pelvic floor muscles. This is PelviLift’s clearest differentiator: “make training feelable,” not “replaces all training.”
“Is it better than doing nothing?” Castro 2008; Cochrane Stewart 2017 Active conservative therapies, including electrical stimulation, outperform no active treatment or sham use. Good claim area: “stop waiting and start activating.”
“Is it better than Kegels?” Bø 1999; Castro 2008; Goode 2003; Cochrane Stewart 2017 Evidence is mixed: some studies show comparable benefit, while classic PFMT trials favor guided training. Do not claim “better than Kegels.” Say “helps when Kegels are hard to feel or perform consistently.”
“Can it help urgency or night urination?” Kurt 2024; Chen 2024; Yu 2024 Some external or intravaginal stimulation studies show improvements in urgency-related urinary outcomes. Use as supportive education, not a guaranteed urgency-treatment claim.
“Is this relevant postpartum?” Cai 2023; Li 2020; postpartum electrical stimulation trials Electrical stimulation has been studied in postpartum pelvic floor weakness and dysfunction contexts. Say “postpartum pelvic floor support.” Avoid “repairs birth injury” or “cures prolapse.”
“Will this improve sex or intimacy?” Aydın 2015; Aalaie 2021; IPSU trial; Piao 2024 Pelvic floor function is linked to intimate confidence, but electrical-stimulation sexual-function evidence is mixed. Use “intimate confidence” and “body response” carefully. Avoid sexual dysfunction treatment claims.
“Does it improve overall quality of life?” QoL meta-analysis 2025; systematic reviews with mixed QoL findings QoL findings are not consistent enough for a primary claim. Do not lead with “improves quality of life.” Use symptom-specific and confidence language instead.

Reference links

Primary sources and clinical literature.

  1. Naidu S, Sherma E, et al. A systematic review of intravaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol. 2026. Used on this site for the study-level figures: 6 of 8 RCTs reported reduced pad use, 10 of 15 reported lower pad weight, and 8 of 14 reported fewer leakage episodes.
  2. FDA 510(k) K213116: FDA database entry
  3. Stewart F, Berghmans B, Bø K, Glazener CMA. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017.
  4. Sand PK, et al. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol. 1995. Used on this site for the patient-level figure: 62% of active-device patients had pad-test leakage improve by at least 50%, compared with 19% using sham devices.
  5. Han Y, et al. Efficacy and safety of electrical stimulation for stress urinary incontinence in women. Int Urogynecol J. 2021.
  6. Castro RA, et al. Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment. Clinics. 2008.
  7. Goode PS, et al. Behavioral training with or without pelvic floor electrical stimulation for stress incontinence in women. JAMA. 2003.
  8. Bø K, et al. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment. BMJ. 1999.
  9. Intravaginal electrical stimulation for women unable to voluntarily contract pelvic floor muscles. PubMed record PMID 34952812.
  10. Li et al. Electrical stimulation protocols for postpartum women with extremely weak pelvic floor muscles. Medicine. 2020.
  11. Cai X, et al. Electrical stimulation therapy for postpartum pelvic floor dysfunction: systematic review and meta-analysis. Front Med. 2023.
  12. Kurt TB, Yilmaz B, Celenay ST. External neuromuscular electrical stimulation in women with urgency urinary incontinence. World J Urol. 2024.
  13. Chen R, et al. Intravaginal electrical stimulation for pelvic floor dysfunction: systematic review and meta-analysis. Front Neurol. 2024.
  14. Aydın S, et al. Assessment of the effectiveness of vaginal electrical stimulation in female sexual dysfunction. J Sex Med. 2015.
  15. IPSU trial. Pelvic floor muscle training with or without electrical stimulation in women with urinary incontinence and sexual dysfunction.
  16. Aalaie B, et al. Biofeedback versus electrical stimulation for female sexual dysfunction. Int Urogynecol J. 2021.
  17. Piao et al. Intravaginal electrical stimulation combined with pelvic floor muscle training for female sexual dysfunction with overactive bladder. J Pers Med. 2024.
  18. Yu TY, et al. Comparison of nonimplantable electrical stimulation in women with urinary incontinence. Scientific Reports. 2024.
  19. Quality-of-life meta-analysis. Electrical stimulation and quality of life in women with urinary incontinence. Scientific Reports. 2025.

Important note

This page summarizes published research on pelvic floor electrical stimulation and related conservative pelvic floor interventions. Individual results may vary. Do not use pelvic floor electrical stimulation if you are pregnant, have a pacemaker or implanted electronic device, have unexplained bleeding, active pelvic infection, pelvic pain, recent pelvic surgery, or if a clinician has advised against use. Always follow product instructions.